期刊文献+

市级医院与Mohnarin全国细菌耐药监测的对照研究Δ 被引量:3

Study of Bacterial Resistance between Municipal Hospitals and Mohnarin Report
原文传递
导出
摘要 目的:比较市级医院与Mohnarin全国细菌耐药监测结果(Mohnarin监测网)的差异,了解福建省市级医院常见分离菌对抗菌药物的耐药性。方法:收集2011年福建省8所市级医院细菌耐药性监测数据,以WHONET 5.6软件进行数据分析,并与Mohnarin监测网进行对照研究。结果:共获得8所市级医院临床分离菌21 960株,其中革兰阳性菌8 081株,占36.8%;革兰阴性菌13 879株,占63.2%。金黄色葡萄球菌中甲氧西林耐药株的检出率为36.3%,低于Mohnarin监测网50.5%的比例,未发现万古霉素、替考拉宁和利奈唑胺耐药株。大肠埃希菌和肺炎克雷伯菌中产超广谱β-内酰胺酶株的检出率分别为53.9%、34.7%,分别低于Mohnarin监测网71.2%、50.3%的比例。肠杆菌科细菌对碳青霉烯类仍高度敏感。不动杆菌对抗菌药物的耐药率明显高于铜绿假单胞菌,对亚胺培南及美罗培南的耐药率分别为55.9%、56.5%。结论:市级医院的细菌耐药性水平与Mohnarin监测网存在一定差异,因此建立本地区的细菌耐药监测网,可以及时了解本地的细菌耐药性特点及发展趋势。 OBJECTIVE: To compare the monitoring of bacterial resistance between municipal hospitals and Mohnarin report, and to investigate the susceptibility of clinical bacterial isolates from municipal hospitals in Fujian province. METHODS: All the bacterial susceptibility results were collected from 8 municipal hospitals in Fujian province in 2011 and data was processed using WHONET 5.6 software. A comparative analysis was conducted with Mohnarin 2011. RESULTS: A total of 21 960 bacterial isolates were collected, including 8 081 (36.8%) strains of gram-positive bacteria and 13 879 (63.2%) strains of gram-negative bacteria. The average prevalence of methicillin-resistant strains in S. aureus (MRSA) was 36.3%, which was lower than 50.5% of Mohnarin monitoring network, and no Staphylococcal strain was found resistant to vancomycin, teicoplanin or linezolid. The preva- lence of ESBLs producing strains was 53.9% in E. coli and 34.7% in K. pneumoniae, which were lower than 71.2% and 50.3% of Mohnarin monitoring network. Enterobacteriaceae strains were still highly susceptible to carbapenems. Drug resistance of Acineto- bacter was significantly higher than that of P. aeruginosa. About 55.9% and 56.5 % of Acinetobacter strains were resistant to imipen- em and meropenem, respectively. CONCLUSIONS: There are some differences in bacterial resistance between municipal hospitals and Mohnarin report, therefore we can keep abreast of local bacterial resistance characteristics and trends if monitoring network of bacterial resistance in the region can be established.
出处 《中国药房》 CAS CSCD 2014年第14期1280-1282,共3页 China Pharmacy
基金 福建省卫生厅青年科研课题(No.2011-2-50)
关键词 市级医院 细菌 耐药 监测 Municipal hospitals Bacteria Drug resistance Surveillance
  • 相关文献

参考文献7

  • 1卫生部.卫生部办公厅《关于抗菌药物临床应用管理有关问题的通知》[EB/0L].[2009-03-23].http://www.nhfpc.gov.cn/bgt/s9508/200903/5ldd05f830cc4ef389dc4c97a8c74720.shill.
  • 2金少鸿,马越.国内细菌耐药性监测研究的回顾与展望[J].中国抗生素杂志,2005,30(5):257-259. 被引量:53
  • 3肖永红,沈萍,魏泽庆,陈云波,孔海深,杨青,张伟丽,陈晓,李兰娟.Mohnarin 2011年度全国细菌耐药监测[J].中华医院感染学杂志,2012,22(22):4946-4952. 被引量:367
  • 4胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:529
  • 5沈德莉,黄仲义,范瑛,孙惠丽,赵永红.抗菌药使用与金黄色葡萄球菌耐药率变化相关分析[J].药物流行病学杂志,2005,14(4):244-246. 被引量:9
  • 6Bertrand X. Methicillin-resistant Staphylococcus aureus. an ever emerging threat[J]. Future Medicine, 2010,7 (2) : 169.
  • 7Lepper PM, Grusa E, Reichl H, et al. Consumption of imi- penem correlates with 13-1actam resistance in pseudomo- has aeruginosa[J].Antimicrobial Agents and Chemothera- py, 2002,46(9) : 2 920.

二级参考文献18

  • 1XIONG Zi-zhong ZHU De-mei WANG Fu ZHANG Ying-yuan.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates[J].Chinese Medical Journal,2006(2):160-164. 被引量:13
  • 2Walther SM, Erlandsson M, Burman LG, et al. Antibiotic prescription practices, consumption and bacterial resistance in across section of Swedish intensive care units [ J ]. Acta Anaesthesiol Scand ,2002 ,46( 9 ) : 1075-1081
  • 3Cizman M, Pokorn M, Seme K, et al. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens [ J ]. J Antimicrob Chemother ,2001,47 (4) :475-477
  • 4Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant staphylococcus aureus and ceftazidime -resistsnt Klebsiella pneumoniae following changes in a hospital antibiotic formulary [ J ]. Clin Infect Dis,1999,28 (5): 1062-1066
  • 5Lesch CA, Itokazu GS, Danziger LH, et al. Multi-hospital analysis of antimicrobial usage and resistance trends [ J ].Diagn Microbiol Infect Dis,. 2001,41 (3) :149-154
  • 6Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 7Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 8Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 9Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 10Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.

共引文献927

同被引文献33

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部